Literature DB >> 19515280

Paraneoplastic movement disorders.

Shyamal H Mehta1, John C Morgan, Kapil D Sethi.   

Abstract

Neurologic paraneoplastic syndromes (NPSs) result from damage to the nervous system due to the remote effects of cancer not related to metastasis, infection, or metabolic derangements. NPSs are rare, affecting 1 in 10,000 patients with cancer. Pathogenesis is likely related to the immune mechanisms: normal neural tissue is mistakenly attacked due to the similarity in the onconeural antigens expressed by the tumor cells. Among the various "classic" and other NPSs, this review focuses on paraneoplastic movement disorders, including ataxia due to cerebellar degeneration, stiff-person syndrome, opsoclonus-myoclonus syndrome, chorea, parkinsonism, and tremor. The recently described syndrome of paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis is also included, given that these patients have complex movements such as stereotypies and dyskinesias in addition to psychiatric symptoms, altered sensorium, and other neurologic signs. Although variable, treatment and prognosis of NPSs rely heavily on treatment of the underlying malignancy and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515280     DOI: 10.1007/s11910-009-0043-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  51 in total

Review 1.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

2.  Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies.

Authors:  P Krolak-Salmon; G Androdias; D Meyronet; M Aguera; J Honnorat; A Vighetto
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

3.  Successful treatment of paraneoplastic cerebellar degeneration with Rituximab.

Authors:  Marcello Esposito; P Penza; G Orefice; A Pagano; E Parente; A Abbadessa; V Bonavita
Journal:  J Neurooncol       Date:  2007-10-09       Impact factor: 4.130

4.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

5.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

6.  CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

Authors:  Z Yu; T J Kryzer; G E Griesmann; K Kim; E E Benarroch; V A Lennon
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

7.  Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.

Authors:  Elizabeth D Tate; Tyler J Allison; Michael R Pranzatelli; Steven J Verhulst
Journal:  J Pediatr Oncol Nurs       Date:  2005 Jan-Feb       Impact factor: 1.636

8.  Progressive supranuclear palsy: paraneoplastic effect of bronchial carcinoma.

Authors:  J Jankovic
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

9.  GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma.

Authors:  John C McHugh; Brian Murray; Radhakrishnan Renganathan; Sean Connolly; Tim Lynch
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

Review 10.  EFNS task force--therapy of nystagmus and oscillopsia.

Authors:  A Straube; R J Leigh; A Bronstein; W Heide; P Riordan-Eva; C C Tijssen; I Dehaene; D Straumann
Journal:  Eur J Neurol       Date:  2004-02       Impact factor: 6.089

View more
  6 in total

1.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

2.  Parkinsonism secondary to metastatic lesions within the central nervous system: a case report.

Authors:  Eduardo Hortelano; Christian Perea; Esther Uña; Amelia Cebayos; Patricia Diezhandino; Montserrat González
Journal:  J Med Case Rep       Date:  2010-07-21

3.  Rapid Eye Movement Sleep Behavior Disorder in Paraneoplastic Cerebellar Degeneration: Improvement with Immunotherapy.

Authors:  Thiago Cardoso Vale; Lucila Bizari Fernandes do Prado; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini; José Luiz Pedroso
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

4.  Unilateral predominance of abnormal movements: A characteristic feature of the pediatric anti-NMDA receptor encephalitis?

Authors:  Vanessa Benjumea-Cuartas; Monika Eisermann; Hina Simonnet; Marie Hully; Rima Nabbout; Isabelle Desguerre; Anna Kaminska
Journal:  Epilepsy Behav Case Rep       Date:  2017-01-18

5.  MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review.

Authors:  Vito A G Ricigliano; Barbara Fossati; Lorenzo Saraceno; Michele Cavalli; Elena Bazzigaluppi; Giovanni Meola
Journal:  Front Neurosci       Date:  2018-01-24       Impact factor: 4.677

Review 6.  Review of Hereditary and Acquired Rare Choreas.

Authors:  Daniel Martinez-Ramirez; Ruth H Walker; Mayela Rodríguez-Violante; Emilia M Gatto
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.